When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APRE - Aprea Therapeutics nabs accelerated review status in U.S. for APR-246
Aprea Therapeutics Inc.
Thinly traded Aprea Therapeutics (APRE-0.2%) announces Breakthrough Therapy status in the U.S. for lead candidate APR-246, combined with chemo agent azacitidine, for the treatment of myelodysplastic syndromes (MDS) with a susceptible TP53 mutation.
More news on: Aprea Therapeutics, Inc., Healthcare stocks news,